Fayetteville | 479-755-4510
Bentonville | 479-777-0657
Schedule Now

CyPass - New Glaucoma Treatments (MIGS) - Arkansas*

Services ( View All )

Glaucoma Surgery Today

Losing your vision slowly day by day can be scary and often leaves patients with a hopeless feeling. The diagnosis of glaucoma, an eye condition that affects the eye's optic nerve, use to be considered a disease without options. Today, however, there are numerous treatments that have paved the way for ophthalmologists to help their patients with advanced procedures. Diagnosing glaucoma in the earliest of stages is critical so that treatment can begin immediately. While some patients may be candidates for treatments such as eye drops or medications, many are ready and need surgery. Thanks to MIGS, micro-invasive glaucoma surgery, there are various options to consider. The CyPass, offered at Vold Vision in Northwest Arkansas has been a game-changer for thousands of patients.

CYpass, The Start of MIGS

A world leader in glaucoma care, Dr. Vold is on the cutting edge of MIGS procedures. In September of 2016, Dr. Vold became the first surgeon in the United States to perform the new glaucoma CyPass Micro-Stent procedure, after its approval by the FDA. The goal of any glaucoma surgery is to lower eye pressure and to prevent or reduce damage to the optic nerve. The MIGS procedures are also proving helpful in reducing glaucoma patients’ dependency on drops, which in many cases requires a higher dosage over time. The CyPass was designed to reduce intraocular pressure (IOP) in glaucoma patients with mild to moderate glaucoma, many of whom are also candidates for cataract surgery.  People travel from across the United States to have this procedure at Vold Vision and the outcomes continue to inspire and create excitement among the industry.

About The CyPass

The CyPass Micro-Stent was one of the first MIGS procedures introduced to glaucoma patients. It is a very tiny tube that is carefully and strategically inserted into the eye, just beneath the white area of the eyeball. This tube relieves pressure and helps reduce the need for eye and glaucoma medications. The procedure is seamless and does not create discomfort for our patients. In fact, the implant is so small, measuring just 6.3 mm in length and .5 mm wide. It is made of plastic and does not have any adverse reactions to the human body.  While the CyPass is designed to be used during cataract surgery, it works wonderful for patients who have open-angle glaucoma, allowing fluid to drain and pressure to ease.

Life-Changing Outcomes

John's Story

John Forberg, a happy Vold Vision patient, tells his story of glaucoma with the sound of hope in his voice and a brightness in his eyes, that now have him seeing with better than 20/20 vision. It has been a long road for John and his wife, Vanda, and they hope to encourage others who find themselves struggling with glaucoma, or as many know it — the "silent thief of sight".

When John first received the diagnosis of glaucoma, his mind immediately went to his mom, who he watched slowly lose her eye sight to the disease. “When the doctor told me, it wasn’t as bad as if someone had said I had cancer, but it was pretty close,” John shared. “I was imagining the worst. I saw what my mom had gone through. The last eight years of her life without her sight was so hard on her.” John had already lost some of his sight from glaucoma, the second leading cause of irreversible blindness in the United States. With little to no symptoms, patients often do not realize they have the eye disease until they notice loss in their peripheral vision.

One of John’s friends heard his news, and told him about Dr. Steven Vold in Northwest Arkansas. John was anxious for help. “When we met Dr. Vold, he came in and looked over my charts and test results. Then he reached over and patted me on my shoulder and said, ‘John, I’m going to be able to you.’ It was a moment I will never forget,” John shared. Vanda remembers it as well, “We were looking at each other like 'really?', and sure enough he did.”

Dr. Vold and his team’s help came in the form of the CyPass. He coupled the Cypass with cataract surgery using an extended range of vision lens. “Glaucoma is a scary disease, and one that can emotionally impact both the patient and their spouse,” Dr. Vold shared. “When I walked in and met John and Vanda, I could see the worry and concern in their faces and was thankful we could help.”

After having the CyPass treatment and having his glaucoma under control allows John and Vanda to breath a bit easier these days, and given John’s 20/15 vision from cataract surgery, he is also enjoying his active lifestyle. “My world had become less and less out of focus,” John said. “My glaucoma and cataracts were stealing my quality of life. It feels great to have my vision back that’s for sure.”

John and Vanda continue to make the drive from Clarksville, Arkansas to see Dr. Vold and stay on top of John’s condition. “One thing I know about Dr. Vold is he loves what he does. It’s not just a job for him. It’s personal,” John said. “I am a very active person, so my eye-sight is everything. I tell everyone I know who even thinks they may have glaucoma to go see him. What he has done for us is a tremendous blessing.”

Request Consultation

Plan Your Procedure

Contact Us

Discover more about CyPass

If you have moderate to advanced glaucoma or painful or vision-impairing uncontrolled pressure in your eye, despite using medication such as eye drops or having had other procedures, CyPass may be an option for you. Dr. Vold takes great care of every patient, spending time analyzing each case carefully so that a thorough and effecive diagnosis and treatment plan can be created. The CyPass, manufacutred by world-leading Alcon, shows that eye pressure is reduced by 34% in the first year following surgery and can eliminate the need for medication.

*Individual results are not guaranteed and may vary from person to person. Images may contain models.